DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Australia
  • /
  • Healthcare
Author Program NEWCreate Narrative
ALC logo

Alcidion Group Limited Stock Price

ASX:ALC Community·AU$133.0m Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 27 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

ALC Share Price Performance

AU$0.099
0.00 (4.21%)
​
AU$0.15
Fair Value
AU$0.099
0.00 (4.21%)
32.9% undervalued intrinsic discount
AU$0.15
Fair Value
Price AU$0.099
AnalystConsensusTarget AU$0.15
Thu, 4 Jun 26
Fair ValueAU$0.15
Share Pricen/a

ALC Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value AU$0.15 32.9% undervalued intrinsic discount

International Expansion Will Accelerate Healthcare Digital Transformation

0users have liked this narrative
0users have commented on this narrative
20users have followed this narrative
ALC logo
Alcidion Group
32.9% undervalued intrinsic discount

International Expansion Will Accelerate Healthcare Digital Transformation

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 4 Jun
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
ALC logo

ALC: FY26 Revenue Visibility And Margin Improvement Will Support Higher Multiple

Fair Value: AU$0.15 32.9% undervalued intrinsic discount
20 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

2 Risks
4 Rewards
View Full Analysis

Alcidion Group Limited Key Details

AU$51.6m

Revenue

AU$10.2m

Cost of Revenue

AU$41.5m

Gross Profit

AU$39.2m

Other Expenses

AU$2.3m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
0.0017
80.28%
4.42%
0%
View Full Analysis

About ALC

Founded
2000
Employees
141
CEO
Kate Quirke
WebsiteView website
www.alcidion.com

Alcidion Group Limited, together with its subsidiaries, develops and sells digital health software solutions for healthcare organisations in Australia, New Zealand, and the United Kingdom. It offers Miya Precision, a fast healthcare interoperability resource (FHIR) events platform that integrates digital patient care services, such as a clinical decision support system, electronic patient record (EPR), and patient administration systems (PAS). The company's platform also provides electronic patient flow journey boards; virtual care and remote patient management; integrated care system smart operations center; emergency department and specialized care; real-time data integration, FHIR-based interoperability, and predictive analytics; modern modular EPR; and streamlined clinical workflows, intelligent comms, and mobility solutions. In addition, the company offers Smartpage, a smartphone and web-based system for hospital communication and task management; and product implementation, product support and maintenance, systems integration, and data analysis services. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. Alcidion Group Limited was founded in 2000 and is headquartered in South Yarra, Australia.

Recent ALC News & Updates

Recent updates

No updates

Alcidion Group Limited Competitors

ACL logo

Australian Clinical Labs

Symbol: ASX:ACL
Market cap: AU$532.9m
MVF logo

Monash IVF Group

Symbol: ASX:MVF
Market cap: AU$307.8m
HLS logo

Healius

Symbol: ASX:HLS
Market cap: AU$275.9m
PGC logo

Paragon Care

Symbol: ASX:PGC
Market cap: AU$231.7m
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide